CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
136101-26-3 | | 4'-(4-pentyl-cyclohexyl)-4-(trifluoro-methanesulfonyl)-biphenyl | C24H29F3O2S | 438.55 | | |
136101-27-4 | | 4-pentyl-cyclohexanecarboxylic acid 4-(trifluoro-methanesulfonyl)-phenyl ester | C19H25F3O4S | 406.46 | | |
136101-29-6 | | 4-(4-propyl-cyclohexyl)-benzenesulfonyl fluoride | C15H21FO2S | 284.39 | | |
136101-30-9 | | 4'-propyl-biphenyl-4-sulfonyl fluoride | C15H15FO2S | 278.34 | | |
136101-31-0 | | 4'-(4-propyl-cyclohexyl)-biphenyl-4-sulfonyl fluoride | C21H25FO2S | 360.48 | | |
136101-34-3 | | 2,2,2-trifluoro-1-[4-(4-pentyl-cyclohexyl)-phenyl]-ethanone | C19H25F3O | 326.40 | | |
136101-35-4 | | 2,2,2-trifluoro-1-[4-(4-heptyl-cyclohexyl)-phenyl]-ethanone | C21H29F3O | 354.45 | | |
136101-36-5 | | 2,2,2-trifluoro-1-(4'-pentyl-biphenyl-4-yl)-ethanone | C19H19F3O | 320.35 | | |
136101-38-7 | | 4-pentyl-cyclohexanecarboxylic acid 4-trifluoroacetyl-phenyl ester | C20H25F3O3 | 370.41 | | |
136101-39-8 | | 4-pentyl-benzoic acid 4-trifluoroacetyl-phenyl ester | C20H19F3O3 | 364.36 | | |
136101-42-3 | | 2,2,2-trifluoro-1-[4-(4-pentyl-cyclohexylmethoxy)-phenyl]-ethanone | C20H27F3O2 | 356.42 | | |
136101-43-4 | | 2,2-difluoro-1-[4-(4-pentyl-cyclohexyl)-phenyl]-ethanone | C19H26F2O | 308.41 | | |
136101-46-7 | | 2,2-difluoro-1-[4-(4-heptyl-cyclohexyl)-phenyl]-propan-1-one | C22H32F2O | 350.49 | | |
136101-47-8 | | 2,2-difluoro-1-[4-(4'-propyl-bicyclohexyl-4-yl)-phenyl]-propan-1-one | C24H34F2O | 376.52 | | |
136101-49-0 | | 2,2-difluoro-1-[4-(4-pentyl-cyclohexyl)-phenyl]-pentan-1-one | C22H32F2O | 350.49 | | |
136101-51-4 | | 2,2-difluoro-1-[4'-(4-pentylcyclohexyl)biphenyl-4-yl]-1-pentanone | C28H36F2O | 426.58 | | |
1361013-63-9 | methyl 4-amino-1-[(2R,4S,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]tetrahydrofuran-2-yl]-2-oxo-pyrimidine-5-carboxylate | | C23H43N3O6Si2 | 513.7733 | | |
1361019-05-7 | 3,5-二溴-1-甲基-1h-吡唑 | 3,5-dibromo-1-methyl-1h-pyrazole | C4H4Br2N2 | 239.90 | | |
1361019-08-0 | 5-(2,6-二氟苯基)-1-甲基-1H-吡唑-3-羧酸乙酯 | Ethyl 5-(2,6-difluorophenyl)-1-methyl-1h-pyrazole-3-carboxylate | C13H12F2N2O2 | 266.24 | | |
1361024-52-3 | 非马沙坦杂质1 | fimasartan impurity 1 | | | | |
1361028-94-5 | 甲基(2S,4R)-4-((3-氯-7-甲氧基喹唑-2-基)氧基)吡咯烷-2-羧酸甲酯 | methyl (2S)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-2-carboxylate hydrochloride | C15H17Cl2N3O4 | 374.22 | | |
136103-68-9 | | n-(3-(4-azido-3-iodophenyl)propionamide)-6-aminoethylcarbamylforskolin | | | | |
136103-77-0 | 2-(噻吩-2-基)-1h-咪唑 | 2-(thiophen-2-yl)-1h-imidazole | | | | |
1361030-48-9 | | ldc1267 | C30H26F2N4O5 | 560.55 | | |
1361034-02-7 | 4-溴-7-(5'-己基-[2,2'-联噻吩]-5-基)-[1,2,5]噻二唑并[3,4-c]吡啶 | 4-Bromo-7-(5'-hexyl-[2,2'-bithiophen]-5-yl)-[1,2,5]thiadiazolo[3,4-c]pyridine | C19H18BrN3S3 | 464.47 | | |
1361046-91-4 | 4,4,5,5-四甲基-2-(1-(4-(三氟甲基)苯基)乙烯基)-1,3,2-二氧硼杂环戊烷 | 4,4,5,5-Tetramethyl-2-(1-(4-(trifluoromethyl)phenyl)vinyl)-1,3,2-dioxaborolane | C15H18BF3O2 | 298.11 | | |
136105-25-4 | | 3-oxetanedimethanol, 4-(4-amino-7h-imidazo(4,5-d)-1,2,3-triazin-7-yl)- (2S-( | | | | |
136105-26-5 | | 2,3-oxetanedimethanol, 4-(4-amino-7h-imidazo(4,5-d)-1,2,3-triazin-7-yl)-2- (dih | | | | |
136105-40-3 | 1,4-二溴-2-(溴甲基)苯 | 1,4-Dibromo-2-(bromomethyl)benzene | C7H5Br3 | 328.83 | | |
136105-62-9 | | gossylic iminolactone | | | | |
136105-89-0 | | (deamino-cys1 | C45H63N15O11S2 | 1054.20 | | |
1361055-01-7 | 5-(11bS)-二萘并[2, 1-d: 1', 2'-f][1, 3, 2]二氧磷杂环庚-4-基-10, 11-二氢-5H-二苯并[b, f]氮杂卓 | 5-(11bS)-Dinaphtho[2, 1-d: 1', 2'-f][1, 3, 2]dioxaphosphepin-4-yl-10, 11-dihydro-5H-dibenz[b, f]azepine | C34H24NO2P | 509.53 | | 699.4±65.0 °C(Predicted) |
1361055-04-0 | 5-[(11ar)-10,11,12,13-四氢二茚基[7,1-de:1',7'-fg] [1,3,2] 二氧膦 -5-基] -5h-二苯并 [b ,f]氮杂 | 5-[(11ar)-10,11,12,13-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]-5h-dibenz[b,f]azepine | C31H24NO2P | 473.50 | | |
1361055-07-3 | (11AS)-5-(4, 5, 6, 7-四氢二茚[7, 1-de: 1', 7'-fg][1, 3, 2]dioxaphosphocin-12-基)-5H-二苯并[b, f]氮杂环庚烯 | (11AS)-5-(4, 5, 6, 7-tetrahydrodiindeno[7, 1-de: 1', 7'-fg][1, 3, 2]dioxaphosphocin-12-yl)-5H-dibenzo[b, f]azepine | C31H24NO2P | 473.50 | | |
1361058-62-9 | 6-氨基-5-氟-3-氰基吡啶 | 6-Amino-5-fluoronicotinonitrile | C6H4FN3 | 137.11 | | |
1361058-63-0 | 叔-丁基 4-(4-氰基-1H-吡唑-1-基)哌啶-1-甲酸基酯 | tert-Butyl 4-(4-cyano-1H-pyrazol-1-yl)piperidine-1-carboxylate | C14H20N4O2 | 276.33 | | |
136107-94-3 | 重组Annexin V 蛋白 | Annexin V, Recombinant | | | | |
136109-04-1 | | ly 274614 | | | | |
1361091-98-6 | 5-甲氧基喹啉-3-甲酸 | 5-methoxyquinoline-3-carboxylic acid | C11H9NO3 | 203.1900 | | |
13611-97-7 | | 17-alpha-pregn-20-yn-3-one, 17-hydroxy-5-alph | | | | |
136111-34-7 | | levr protein | | | | |
136111-36-9 | | heat shock factor, human | | | | |
1361110-63-5 | 3-氯-4-(4-吗啉基)苯硼酸频哪醇酯 | 3-chloro-4-morpholinophenylboronic acid pinacol ester | C16H23BClNO3 | 323.62 | | |
1361110-64-6 | 3,4-二氢-2h-1,4-苯并噁嗪-7-硼酸频哪醇酯 | 3,4-dihydro-2h-1,4-benzoxazine-7-boronic acid pinacol ester | C14H20BNO3 | 261.13 | | |
1361111-50-3 | | 4-(pyridin-3-ylmethyl)oxane-4-carboxylic acid | | | | |
1361111-78-5 | 1-乙酰基-4-(叔丁氧基羰基)哌嗪-2-羧酸 | 1-Acetyl-4-(tert-butoxycarbonyl)piperazine-2-carboxylicacid | C12H20N2O5 | 272.3 | | |
1361112-04-0 | | tert-butyl 3-[2-(2-aminopyridin-4-yl)ethyl]piperidine-1-carboxylate | | | | |
1361112-29-9 | | 5-methyl-2-(piperidin-3-ylmethyl)pyridine dihydrochloride | | | | |
1361112-46-0 | 叔丁基3-(哌啶-4-基)-5,6-二氢-[1,2,4]三唑并[4,3-a]吡嗪-7(8H)-羧酸酯 | tert-Butyl3-(piperidin-4-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate | C15H25N5O2 | 307.4 | | |
1361112-87-9 | | 2-(1-acetylpyrrolidin-2-yl)-5-bromo-4-methyl-1,3-thiazole | | | | |